1. Home
  2. SONM vs TCRT Comparison

SONM vs TCRT Comparison

Compare SONM & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonim Technologies Inc.

SONM

Sonim Technologies Inc.

HOLD

Current Price

$2.89

Market Cap

7.4M

ML Signal

HOLD

Logo Alaunos Therapeutics Inc.

TCRT

Alaunos Therapeutics Inc.

HOLD

Current Price

$3.20

Market Cap

8.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SONM
TCRT
Founded
1999
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4M
8.1M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
SONM
TCRT
Price
$2.89
$3.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
59.5K
57.0K
Earning Date
10-31-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$59,109,000.00
$6,000.00
Revenue This Year
$127.68
$5,680,500.00
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.17
N/A
52 Week Low
$2.52
$1.31
52 Week High
$114.84
$6.20

Technical Indicators

Market Signals
Indicator
SONM
TCRT
Relative Strength Index (RSI) 30.77 42.57
Support Level $2.52 $3.13
Resistance Level $3.40 $4.50
Average True Range (ATR) 0.58 0.27
MACD -0.16 -0.09
Stochastic Oscillator 9.48 12.95

Price Performance

Historical Comparison
SONM
TCRT

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the Canada, and to Bell, Rogers, and Telus and Rogers, Telstra in Australia. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a preclinical stage obesity and metabolic health drug development company that is aiming to develop a small molecule-based drug to treat obesity and other metabolic disorders that have a differentiated profile relative to currently marketed and in development oral and injectable products. The company focuses on evaluating the impact of ALN1001, its primary program, and its derivatives on lipid deposition and gene expression. It aims to develop an oral obesity compound that addresses many of the shortcomings of injectable GLP-1 receptor agonists including preserving lean muscle mass.

Share on Social Networks: